Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
A Phase III, Multi-centre, Randomized Study to Compare the Efficacy and Safety of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Sponsor: Wockhardt
A PHASE3 clinical study on Acute Bacterial Skin and Skin Structure Infections, this trial is completed. The trial is conducted by Wockhardt and has accumulated 9 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Sep 2019 — Jul 2020 [monthly]
Completed PHASE3
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Nov 2018 — Sep 2019 [monthly]
Recruiting PHASE3
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE3
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE3
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Wockhardt
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ahmedabad, India , Aurangabad, India , Bangalore, India , Himmatnagar, India , Hyderabad, India , Jaipur, India , Kozhikode, India , Lucknow, India , Mangalore, India , Mumbai, India and 7 more locations